DCF Step by Step Template blank.xlsx

Unlevered free cash flow 398 155 237 dividend per 237

This preview shows page 72 - 80 out of 82 pages.

Unlevered Free Cash Flow 34.9% 9.9% (23.4%) 39.8% 15.5% 23.7% Dividend per Share 0.0% 0.0% 23.7% 26.8% 17.2% 10.3% Compound Annual Growth Rate Over Two Years Total Revenue 5.2% 4.5% 6.9% 9.1% 5.6% 2.0% Gross Profit 3.9% 11.1% 13.8% 13.8% 8.8% 1.7%
Image of page 72
EBITDA 3.4% 11.0% 13.4% 15.3% 10.6% 2.6% EBITA 2.0% 15.2% 17.0% 17.8% 11.8% 2.6% EBIT 3.4% 16.0% 17.6% 18.3% 12.0% 2.2% Earnings from Cont. Ops. 2.8% 91.1% 34.0% 20.4% 13.4% (16.1%) Net Income 5.1% 89.8% 33.6% 20.1% 13.7% (16.0%) Normalized Net Income 1.6% 20.2% 22.4% 19.1% 12.0% 2.4% Diluted EPS before Extra 0.7% 85.4% 31.0% 21.8% 17.3% (13.0%) Accounts Receivable (3.9%) (6.2%) 7.1% 3.8% 6.6% 7.0% Inventory (4.3%) (1.6%) 10.1% 6.9% 4.7% 0.2% Net PP&E (5.0%) (1.6%) 4.1% 4.4% 7.2% 6.8% Total Assets (3.6%) 1.9% 9.6% 2.4% 6.5% 6.5% Tangible Book Value 38.6% 66.3% 45.5% 0.1% 0.9% (1.6%) Common Equity 12.7% 30.1% 26.8% (0.3%) 2.0% 2.7% Cash from Ops. 4.3% 25.8% 21.9% 7.3% 12.3% 9.3% Capital Expenditures (25.1%) (2.9%) 24.8% 34.7% 21.1% 0.5% Levered Free Cash Flow 126.1% 24.5% (7.7%) 2.5% 29.3% 21.5% Unlevered Free Cash Flow 103.4% 21.7% (8.2%) 3.5% 27.1% 19.5% Dividend per Share 0.0% 0.0% 11.2% 25.2% 21.9% 13.7% Compound Annual Growth Rate Over Three Years Total Revenue 6.7% 5.2% 5.8% 7.8% 6.6% 4.5% Gross Profit 4.1% 6.9% 12.2% 13.6% 10.7% 5.3% EBITDA 2.9% 5.5% 13.0% 13.5% 12.7% 6.1% EBITA 0.5% 5.5% 17.2% 16.1% 14.9% 6.4% EBIT 1.0% 6.7% 17.9% 16.7% 15.2% 6.3% Earnings from Cont. Ops. (2.3%) 15.5% 65.0% 28.3% 16.6% (6.1%) Net Income 7.4% 17.3% 63.9% 28.2% 16.4% (6.0%) Normalized Net Income (1.8%) 7.9% 21.1% 20.0% 15.5% 6.5% Diluted EPS before Extra (2.9%) 12.4% 61.5% 27.6% 19.0% (2.9%) Accounts Receivable (0.5%) (1.3%) (1.0%) 3.9% 7.8% 3.8% Inventory 3.2% (0.6%) 3.0% 7.0% 7.4% 0.5% Net PP&E 1.9% (2.7%) 0.9% 3.6% 6.9% 5.4% Total Assets 0.8% 2.3% 2.6% 6.6% 5.7% 4.6% Tangible Book Value 29.3% 52.7% 46.7% 22.9% 5.2% (5.3%) Common Equity 12.6% 22.9% 23.1% 13.2% 4.7% (1.7%) Cash from Ops. 9.0% 15.3% 18.6% 17.5% 10.0% 9.2% Capital Expenditures (19.5%) (12.8%) 7.4% 29.0% 24.5% 11.6% Levered Free Cash Flow 31.9% 80.3% 4.8% 6.4% 7.5% 27.8% Unlevered Free Cash Flow 32.0% 65.7% 4.3% 5.6% 7.4% 25.9% Dividend per Share 0.0% 0.0% 7.4% 16.2% 22.5% 17.9%
Image of page 73
Compound Annual Growth Rate Over Five Years Total Revenue 8.0% 7.2% 6.8% 6.8% 5.7% 5.5% Gross Profit 6.9% 7.3% 7.9% 9.6% 10.9% 8.7% EBITDA 5.9% 5.6% 7.0% 9.3% 12.0% 9.0% EBITA 4.5% 4.6% 6.8% 10.3% 15.0% 10.5% EBIT 5.3% 5.4% 7.3% 11.2% 15.5% 10.7% Earnings from Cont. Ops. 4.9% 16.1% 10.9% 17.4% 42.0% 8.3% Net Income 5.3% 18.4% 17.2% 18.4% 41.6% 8.2% Normalized Net Income 3.5% 5.5% 7.2% 12.2% 17.4% 12.6% Diluted EPS before Extra 3.8% 14.3% 9.5% 16.1% 42.1% 9.5% Accounts Receivable 5.0% 2.5% 2.5% 0.7% 1.9% 5.1% Inventory 10.7% 9.0% 5.9% 2.3% 3.7% 4.3% Net PP&E 8.1% 5.0% 2.8% 0.1% 3.4% 4.9% Total Assets 7.8% 7.3% 4.2% 2.4% 4.2% 6.6% Tangible Book Value 9.7% 15.2% 35.6% 29.0% 26.3% 12.5% Common Equity 10.1% 10.8% 18.1% 13.0% 14.2% 8.8% Cash from Ops. 5.7% 14.9% 14.0% 12.0% 16.1% 14.1% Capital Expenditures (6.6%) (7.1%) (4.1%) 3.8% 12.7% 16.7% Levered Free Cash Flow 2.2% 16.8% 14.3% 43.9% 14.0% 12.2% Unlevered Free Cash Flow 2.5% 15.3% 14.1% 37.3% 12.9% 11.0% Dividend per Share 0.0% 0.0% 4.3% 9.4% 13.0% 15.2%
Image of page 74
10.7% 9.9% 8.5% NA 16.9% 15.7% 12.9% 11.7% 33.1% 33.7% 26.0% 23.0% 33.8% 34.4% 26.1% 23.1% 51.4% 51.8% 51.1% 49.3% 22.0% 22.6% 23.4% 22.4% 27.4% 27.0% 26.1% 25.9% 23.2% 22.7% 21.5% 19.9% 22.6% 22.0% 20.7% 19.9% 16.2% 16.4% 13.2% 11.7% 16.0% 16.4% 13.2% 15.0% 16.0% 16.4% 13.2% 11.7% 13.5% 13.7% 12.7% 12.2% 12.1% 8.5% 2.4% NA 12.5% 9.0% 3.1% NA 0.8x 0.7x 0.7x NA 2.6x 2.4x 2.2x NA 5.9x 5.9x 5.7x NA 2.7x 2.5x 2.4x NA 1.8x 1.9x 1.7x NA 1.1x 1.2x 1.0x NA 0.6x 0.7x 0.5x NA 61.5 62.5 63.8 NA 135.1 145.2 154.2 NA 40.1 40.7 41.8 NA 156.6 167.0 176.2 NA 12 months Dec-31-2011 12 months Dec-31-2012 12 months Dec-31-2013 Press Release 12 months Dec-31-2014
Image of page 75
76.1% 85.0% 108.0% 110.1% 43.2% 45.9% 51.9% 52.4% 69.6% 80.0% 95.8% NA 39.5% 43.2% 46.0% NA 64.2% 65.8% 67.2% NA 34.1x 27.6x 20.4x 22.9x 41.4x 33.9x 25.7x 29.7x 31.0x 23.7x 15.8x 29.7x 1.4x 1.5x 2.3x 2.2x 0.6x 0.7x 1.6x 1.7x 1.8x 2.2x 3.7x 2.2x 0.8x 1.0x 2.6x 1.7x 3.72 3.65 3.13 NA 8.2% 2.1% 7.5% 9.3% 10.5% 2.9% 6.2% 5.3% 8.3% 0.7% 3.7% 8.4% 10.7% 0.2% 1.9% 0.9% 10.9% (0.4%) 1.0% 5.1% 58.1% 3.1% (13.5%) (3.3%) 56.6% 4.6% (13.5%) 24.1% 9.6% 3.3% (0.6%) 4.9% 62.3% 7.7% (12.4%) (2.7%) 6.8% 0.2% 20.0% NA 10.8% 6.7% 24.8% NA 5.0% 10.4% 28.4% NA 9.1% 6.9% 26.9% NA (15.1%) 5.2% (45.8%) 327.9% 0.3% 5.4% 22.0% (0.7%) (6.2%) 10.3% 3.0% NA (0.3%) 20.9% 31.4% NA (10.5%) (28.6%) (69.3%) NA (10.8%) (26.9%) (63.4%) NA 7.2% 24.1% 22.3% 6.8% 5.2% 5.1% 4.8% 8.4% 4.4% 6.6% 4.5% 5.7%
Image of page 76
2.9% 4.5% 2.2% 6.0% 3.3% 5.3% 1.0% 1.4% 3.0% 5.1% 0.3% 3.0% 0.9% 27.7% (5.6%) (8.5%) 0.4% 28.0% (4.9%) 3.6% 2.8% 6.4% 1.3% 2.1% 4.0% 32.2% (2.9%) (7.7%) 2.5% 3.5% 9.7% NA 1.4% 8.7% 15.4% NA 3.5% 7.7% 19.1% NA 4.8% 8.0% 16.5% NA (15.8%) (5.5%) (24.5%) 52.3% (4.3%) 2.8% 13.4% 10.1% (1.6%) 1.7% 6.5% NA (2.7%) 9.8% 26.0% NA 5.8% (20.1%) (53.2%) NA 5.0% (19.3%) (48.3%) NA 8.7% 15.3% 23.2% 14.3% 4.0% 4.1% 5.9% 6.3% 4.5% 3.9% 6.5% 4.8% 4.5% 2.2% 4.2% 4.2% 5.2% 2.2% 4.1% 1.0% 5.0% 1.9% 3.7% 1.9% 3.7% 1.6% 12.1% (4.8%) 3.4% 1.8% 12.3% 3.9% 4.8% 2.9% 4.0% 2.5% 7.1% 5.2% 15.3% (2.8%) 6.9% 1.8% 8.7% NA 3.6% 3.1% 13.9% NA 6.2% 5.7% 14.2% NA 7.4% 5.5% 13.9% NA (6.3%) (9.3%) (21.4%) 34.7% 1.9% (1.2%) 8.8% 8.5% 3.9% 2.2% 2.1% NA 0.2% 4.6% 16.6% NA 9.7% (7.2%) (41.9%) NA 8.4% (6.9%) (38.0%) NA 11.5% 13.6% 17.6% 17.5%
Image of page 77
6.0% 4.7% 4.3% 5.8% 8.1% 5.8% 4.5% 4.6% 8.7% 5.5% 3.6% 3.7% 10.1% 6.0% 3.5% 1.9% 10.2% 5.8% 3.1% 2.3% 10.0% 6.2% (0.1%) (2.6%) 9.7% 6.4% (0.0%) 2.5% 10.3% 6.5% 3.4% 2.6% 12.7% 9.9% 3.0% (0.2%) 5.7% 3.7% 8.0% NA 4.9% 3.7% 8.2% NA 5.5% 6.3% 11.2% NA 5.4% 5.9% 10.9% NA (3.8%) (5.4%) (14.0%) 11.6% 1.0% 0.1% 6.3% 3.2% 5.2% 6.1% 4.9% NA 12.8% 10.9% 9.8% NA 6.8% 5.9% (21.9%) NA 6.4% 5.4% (19.4%) NA 16.8% 16.9% 16.0% 13.9%
Image of page 78
Baxter International Inc. (NYSE:BAX) > Financials > Segments
Image of page 79

Want to read all 82 pages?

Image of page 80

Want to read all 82 pages?

You've reached the end of your free preview.

Want to read all 82 pages?

  • Fall '09
  • ?
  • Revenue, Net Income

{[ snackBarMessage ]}

Get FREE access by uploading your study materials

Upload your study materials now and get free access to over 25 million documents.

Upload now for FREE access Or pay now for instant access
Christopher Reinemann
"Before using Course Hero my grade was at 78%. By the end of the semester my grade was at 90%. I could not have done it without all the class material I found."
— Christopher R., University of Rhode Island '15, Course Hero Intern

Ask a question for free

What students are saying

  • Left Quote Icon

    As a current student on this bumpy collegiate pathway, I stumbled upon Course Hero, where I can find study resources for nearly all my courses, get online help from tutors 24/7, and even share my old projects, papers, and lecture notes with other students.

    Student Picture

    Kiran Temple University Fox School of Business ‘17, Course Hero Intern

  • Left Quote Icon

    I cannot even describe how much Course Hero helped me this summer. It’s truly become something I can always rely on and help me. In the end, I was not only able to survive summer classes, but I was able to thrive thanks to Course Hero.

    Student Picture

    Dana University of Pennsylvania ‘17, Course Hero Intern

  • Left Quote Icon

    The ability to access any university’s resources through Course Hero proved invaluable in my case. I was behind on Tulane coursework and actually used UCLA’s materials to help me move forward and get everything together on time.

    Student Picture

    Jill Tulane University ‘16, Course Hero Intern